Patheon Expands PR Facility

Patheon, Inc. is expanding its Manati, PR facility to add a dedicated high potency and controlled substance manufacturing area. The company will invest $2.8 million in a new 3,386-sq.-ft. area that will include three manufacturing suites, air lock containment areas, and humidity controlled air systems.
   
The three manufacturing suites will create one manufacturing area technology transfer, bulk production, bulk packaging, and storage. The production area will have capacity for high potency and humidity-controlled solid dosage form products. Construction is expected to be complete by the end of September 2008.
   
“The Manati expansion is part of our strategy to satisfy the special manufacturing needs of our current and future customers,” said Terry Novak, Patheon’s president of North America and chief marketing officer. “Other Patheon sites have extensive capabilities to manufacture products of this type. The addition of this capability in Puerto Rico provides another high quality manufacturing site option to our customers.”